Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma.
Wrench
David
D
Waters
Rachel
R
Carlotti
Emanuela
E
Iqbal
Sameena
S
Matthews
Janet
J
Calaminici
Marie
M
Gribben
John
J
Lister
T Andrew
TA
Fitzgibbon
Jude
J
D001120:Arginine / Q000235:genetics / Q000378:metabolism; D018450:Disease Progression; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008297:Male; D009154:Mutation / Q000235:genetics; D009367:Neoplasm Staging; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics* / Q000378:metabolism; D015996:Survival Rate; D016159:Tumor Suppressor Protein p53 / Q000235:genetics* / Q000378:metabolism
C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D001120:Arginine; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2